Literature DB >> 20728923

Gleason score correlation between biopsy and prostatectomy specimens and prediction of high-grade Gleason patterns: significance of central pathologic review.

Kentaro Kuroiwa1, Taizo Shiraishi, Seiji Naito.   

Abstract

OBJECTIVES: To investigate the significance of dedicated central pathologic review for Gleason score (GS) correlation between the biopsy and radical prostatectomy (RP) specimens and the prediction of high-grade Gleason patterns. A discrepancy in the GS between the biopsy and RP specimens has been reported.
METHODS: The Clinicopathological Research Group for Localized Prostate Cancer disease registry collated the data from 1629 patients who had undergone RP from 1997 to 2005. All biopsy and RP specimens were retrospectively re-evaluated by 2 central uropathologists according to the International Society of Urological Pathology consensus. The GS correlation between the biopsy and RP specimens and the presence of high-grade Gleason patterns (4 or 5) were recorded. The GS was categorized into 5 groups (2-4, 5-6, 3 + 4, 4 + 3, and 8-10).
RESULTS: Central review significantly increased the exact concordance rate and decreased the undergrading and overgrading rates between the biopsy and RP specimens compared with local review (P < .05 for all). In each GS or prostate-specific antigen group, the central review biopsy GS had a significantly greater exact concordance rate with the RP specimen GS compared with the local review biopsy GS (P < .05 for all). Regarding high-grade Gleason patterns in the RP specimens, central review showed significantly greater sensitivity, positive predictive value, and negative predictive value than local review (P < .05 for all).
CONCLUSIONS: We have demonstrated that central review using the International Society of Urological Pathology consensus improves the GS correlation and better predicts high-grade Gleason patterns compared with local review. We recommend central pathologic review by dedicated uropathologists for multi-institutional studies using data from prostate biopsy and RP specimens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728923     DOI: 10.1016/j.urology.2010.05.030

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

1.  The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy.

Authors:  Attila Majoros; Attila Marcell Szász; Péter Nyirády; Eszter Székely; Péter Riesz; Attila Szendrői; Attila Keszthelyi; Janina Kulka; Imre Romics
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

2.  Clinical impact of prostate biopsy undergrading in an academic and community setting.

Authors:  Ashkan Mortezavi; Etienne Xavier Keller; Cédric Poyet; Thomas Hermanns; Karim Saba; Marco Randazzo; Christian Daniel Fankhauser; Peter J Wild; Holger Moch; Tullio Sulser; Daniel Eberli
Journal:  World J Urol       Date:  2016-03-01       Impact factor: 4.226

Review 3.  Developing a National Center of Excellence for Prostate Imaging.

Authors:  Annerleim Walton-Diaz; Manuel Madariaga-Venegas; Nicolas Aviles; Juan Carlos Roman; Ivan Gallegos; Mauricio Burotto
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

4.  Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.

Authors:  Jonathan I Epstein; Zhaoyong Feng; Bruce J Trock; Phillip M Pierorazio
Journal:  Eur Urol       Date:  2012-02-08       Impact factor: 20.096

5.  Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.

Authors:  Sonja D Chen; Joseph L Fava; Ali Amin
Journal:  Virchows Arch       Date:  2015-11-12       Impact factor: 4.064

6.  Gleason scoring at a comprehensive cancer center: what's the difference?

Authors:  Natasha C Townsend; Karen Ruth; Tahseen Al-Saleem; Eric M Horwitz; Mark Sobczak; Robert G Uzzo; Rosalia Viterbo; Mark K Buyyounouski
Journal:  J Natl Compr Canc Netw       Date:  2013-07       Impact factor: 11.908

7.  Predicting Prostate Cancer Upgrading of Biopsy Gleason Grade Group at Radical Prostatectomy Using Machine Learning-Assisted Decision-Support Models.

Authors:  Hailang Liu; Kun Tang; Ejun Peng; Liang Wang; Ding Xia; Zhiqiang Chen
Journal:  Cancer Manag Res       Date:  2020-12-22       Impact factor: 3.989

8.  Does obesity modify prostate cancer detection in a European cohort?

Authors:  Angeles Sanchis-Bonet; Nelson Morales-Palacios; Marta Barrionuevo-Gonzalez; Luis-Enrique Ortega-Polledo; Francisco-Javier Ortiz-Vico; Manuel Sanchez-Chapado
Journal:  Cent European J Urol       Date:  2017-01-03

9.  Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices.

Authors:  Franklin Lee; Henry Gottsch; William J Ellis; Lawrence D True; Daniel W Lin; Jonathan L Wright
Journal:  Adv Urol       Date:  2013-10-24

10.  Focal lesion at the midline of the prostate on transrectal ultrasonography: take it or leave it?

Authors:  Junwoo Kim; Sung Il Hwang; Hak Jong Lee; Sung Kyu Hong; Seok-Soo Byun; Sangchul Lee; Gheeyoung Choe
Journal:  Ultrasonography       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.